Using robots to help perform prostate cancer surgery has become commonplace and is more effective, a study has found.
The investigation, which was led by experts at Henry Ford Hospital's Vattikuti Urology Institute (VUI) and published in the medical journal European Urology, found using these innovations to aid in the treatment of prostate cancer has a higher success rate than open surgery.
Furthermore, it is more popular in the US than other traditional interventions, the research found.
Researchers analysed 11,889 patients who underwent a robot-assisted radical prostatectomy (RARP) and 7,389 individuals that were treated with an open radical prostatectomy (ORP).
In a study that could impact the medical choices of international medical insurance or other forms of healthcare cover "are more likely to have complications during and after surgery and need much more time in the hospital".
"Better surgical outcomes are expected at academic centres," he pointed out.
Radical prostatectomy (RP) has become the standard way to treat prostate cancer after research revealed it resulted in better survival rates when compared with 'watchful waiting'.
"We've seen a significant trend toward the use of minimally invasive approaches to RP for the treatment of prostate cancer, particularly in the US," Dr Trinh declared.
Symptoms of the condition include difficulty urinating, needing to race to the toilet and a frequent need to pass water.